Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn L Stanfield

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2023
Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulinsLaetitia Misson Mindrebo, Hejun Liu, Gabriel Ozorowski, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Structure and functional diversity of antibodies targeting the <i>P. falciparum</i> circumsporozoite protein C-terminal domainRe'em Moskovitz, Iszac Burton, Nathan Beutler, et al.
Plos Pathogens|May 10, 2013
Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycansJean-Philippe Julien, Devin Sok, Reza Khayat, et al.
Plos Pathogens|September 15, 2016
Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine DesignJoseph G Jardine, Devin Sok, Jean-Philippe Julien, et al.
Plos Pathogens|August 26, 2016
Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine DesignJoseph G Jardine, Devin Sok, Jean-Philippe Julien, et al.
Science Translational Medicine|February 21, 2024
Synthetic development of a broadly neutralizing antibody against snake venom long-chain α-neurotoxinsIrene S Khalek, R R Senji Laxme, Yen Thi Kim Nguyen, et al.
Nature Structural & Molecular Biology|May 28, 2013
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120Leopold Kong, Jeong Hyun Lee, Katie J Doores, et al.
Immunity|September 13, 2016
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing AntibodiesJon M Steichen, Daniel W Kulp, Talar Tokatlian, et al.
Plos Pathogens|November 17, 2022
Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizerJelle van Schooten, Anna Schorcht, Elinaz Farokhi, et al.
Science (New York, N.Y.)|October 15, 2011
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shieldRobert Pejchal, Katie J Doores, Laura M Walker, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2023
Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulinsLaetitia Misson Mindrebo, Hejun Liu, Gabriel Ozorowski, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Structure and functional diversity of antibodies targeting the <i>P. falciparum</i> circumsporozoite protein C-terminal domainRe'em Moskovitz, Iszac Burton, Nathan Beutler, et al.
Plos Pathogens|May 10, 2013
Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycansJean-Philippe Julien, Devin Sok, Reza Khayat, et al.
Plos Pathogens|September 15, 2016
Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine DesignJoseph G Jardine, Devin Sok, Jean-Philippe Julien, et al.
Plos Pathogens|August 26, 2016
Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine DesignJoseph G Jardine, Devin Sok, Jean-Philippe Julien, et al.
Science Translational Medicine|February 21, 2024
Synthetic development of a broadly neutralizing antibody against snake venom long-chain α-neurotoxinsIrene S Khalek, R R Senji Laxme, Yen Thi Kim Nguyen, et al.
Nature Structural & Molecular Biology|May 28, 2013
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120Leopold Kong, Jeong Hyun Lee, Katie J Doores, et al.
Immunity|September 13, 2016
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing AntibodiesJon M Steichen, Daniel W Kulp, Talar Tokatlian, et al.
Plos Pathogens|November 17, 2022
Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizerJelle van Schooten, Anna Schorcht, Elinaz Farokhi, et al.
Science (New York, N.Y.)|October 15, 2011
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shieldRobert Pejchal, Katie J Doores, Laura M Walker, et al.
Pageof 12